Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 50,000 shares at $19.09 ($955K) on 2026-06-30, disclosed to the SEC on 2026-07-02.
Scheduled sale ($954k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |
| RLAY | SELL | 2025-10-30 | $439K | — | Filing → |